全文获取类型
收费全文 | 2288篇 |
免费 | 114篇 |
国内免费 | 81篇 |
专业分类
耳鼻咽喉 | 107篇 |
儿科学 | 114篇 |
妇产科学 | 41篇 |
基础医学 | 280篇 |
口腔科学 | 33篇 |
临床医学 | 290篇 |
内科学 | 557篇 |
皮肤病学 | 84篇 |
神经病学 | 114篇 |
特种医学 | 312篇 |
外国民族医学 | 1篇 |
外科学 | 213篇 |
综合类 | 36篇 |
预防医学 | 88篇 |
眼科学 | 11篇 |
药学 | 112篇 |
肿瘤学 | 90篇 |
出版年
2023年 | 8篇 |
2022年 | 12篇 |
2021年 | 32篇 |
2020年 | 9篇 |
2019年 | 36篇 |
2018年 | 43篇 |
2017年 | 23篇 |
2016年 | 29篇 |
2015年 | 36篇 |
2014年 | 31篇 |
2013年 | 75篇 |
2012年 | 75篇 |
2011年 | 78篇 |
2010年 | 81篇 |
2009年 | 70篇 |
2008年 | 57篇 |
2007年 | 103篇 |
2006年 | 59篇 |
2005年 | 74篇 |
2004年 | 51篇 |
2003年 | 53篇 |
2002年 | 64篇 |
2001年 | 51篇 |
2000年 | 64篇 |
1999年 | 55篇 |
1998年 | 100篇 |
1997年 | 106篇 |
1996年 | 110篇 |
1995年 | 88篇 |
1994年 | 91篇 |
1993年 | 79篇 |
1992年 | 60篇 |
1991年 | 59篇 |
1990年 | 54篇 |
1989年 | 58篇 |
1988年 | 57篇 |
1987年 | 47篇 |
1986年 | 50篇 |
1985年 | 49篇 |
1984年 | 21篇 |
1983年 | 25篇 |
1982年 | 22篇 |
1981年 | 24篇 |
1980年 | 19篇 |
1978年 | 9篇 |
1977年 | 15篇 |
1976年 | 13篇 |
1975年 | 11篇 |
1974年 | 7篇 |
1970年 | 6篇 |
排序方式: 共有2483条查询结果,搜索用时 15 毫秒
101.
Federico di Rocco Geneviève Baujat Eric Arnaud Dominique Rénier Jean-Louis Laplanche Valérie Cormier Daire Corinne Collet 《European journal of human genetics : EJHG》2014,22(12):1413-1416
TCF12 mutations have been reported very recently in coronal synostosis. We report several cases of familial coronal synostosis among four families harbouring novel TCF12 mutations. We observed a broad interfamilial phenotypic spectrum with features overlapping with the Saethre–Chotzen syndrome. TCF12 molecular testing should be considered in patients with unilateral- or bilateral-coronal synostosis associated or not with syndactyly, after having excluded mutations in the TWIST1 gene and the p.Pro250Arg mutation in FGFR3. 相似文献
102.
Erik P A van Iperen Suthesh Sivapalaratnam S Matthijs Boekholdt G Kees Hovingh Stephanie Maiwald Michael W Tanck Nicole Soranzo Jonathan C Stephens Jennifer G Sambrook Marcel Levi Willem H Ouwehand John JP Kastelein Mieke D Trip Aeilko H Zwinderman 《European journal of human genetics : EJHG》2014,22(6):809-813
In recent years, multiple loci dispersed on the genome have been shown to be associated with coronary artery disease (CAD). We investigated whether these common genetic variants also hold value for CAD prediction in a large cohort of patients with familial hypercholesterolemia (FH). We genotyped a total of 41 single-nucleotide polymorphisms (SNPs) in 1701 FH patients, of whom 482 patients (28.3%) had at least one coronary event during an average follow up of 66 years. The association of each SNP with event-free survival time was calculated with a Cox proportional hazard model. In the cardiovascular disease risk factor adjusted analysis, the most significant SNP was rs1122608:G>T in the SMARCA4 gene near the LDL-receptor (LDLR) gene, with a hazard ratio for CAD risk of 0.74 (95% CI 0.49–0.99; P-value 0.021). However, none of the SNPs reached the Bonferroni threshold. Of all the known CAD loci analyzed, the SMARCA4 locus near the LDLR had the strongest negative association with CAD in this high-risk FH cohort. The effect is contrary to what was expected. None of the other loci showed association with CAD. 相似文献
103.
Katherine JP Schwenger Johane P Allard 《World journal of gastroenterology : WJG》2014,20(7):1712-1723
Non-alcoholic fatty liver disease(NAFLD)ranges from simple steatosis to nonalcoholic steatohepatitis(NASH),leading to fibrosis and potentially cirrhosis,and it is one of the most common causes of liver disease worldwide.NAFLD is associated with other medical conditions such as metabolic syndrome,obesity,cardiovascular disease and diabetes.NASH can only be diagnosed through liver biopsy,but noninvasive techniques have been developed to identify patients who are most likely to have NASH or fibrosis,reducing the need for liver biopsy and risk to patients.Disease progression varies between individuals and is linked to a number of risk factors.Mechanisms involved in the pathogenesis are associated with diet and lifestyle,influx of free fatty acids to the liver from adipose tissue due to insulin resistance,hepatic oxidative stress,cytokines production,reduced very low-density lipoprotein secretion and intestinal microbiome.Weight loss through improved diet and increased physical activity has been the cornerstone therapy of NAFLD.Recent therapies such as pioglitazone and vitamin E have been shown to be beneficial.Omega 3 polyunsaturated fatty acids and statins may offer additional benefits.Bariatric surgery should be considered in morbidly obese patients.More research is needed to assess the impact of these treatments on a long-term basis.The objective of this article is to briefly review the diagnosis,management and treatment of this disease in order to aid clinicians in managing these patients. 相似文献
104.
Mice are a widely utilized in vivo model for translational salivary gland research but must be used with caution. Specifically, mouse salivary glands are similar in many ways to human salivary glands (i.e., in terms of their anatomy, histology, and physiology) and are both readily available and relatively easy and affordable to maintain. However, there are some significant differences between the two organisms, and by extension, the salivary glands derived from them must be taken into account for translational studies. The current review details pertinent similarities and differences between human and mouse salivary glands and offers practical guidelines for using both for research purposes. 相似文献
105.
106.
B Gencer TH Collet V Virgini DC Bauer J Gussekloo AR Cappola D Nanchen WP den Elzen P Balmer RN Luben M Iacoviello V Triggiani J Cornuz AB Newman KT Khaw JW Jukema RG Westendorp E Vittinghoff D Aujesky N Rodondi;for the Thyroid Studies Collaboration 《Circulation》2012,126(9):1040-1049
BACKGROUND: American College of Cardiology/American Heart Association guidelines for the diagnosis and management of heart failure recommend investigating exacerbating conditions such as thyroid dysfunction, but without specifying the impact of different thyroid-stimulation hormone (TSH) levels. Limited prospective data exist on the association between subclinical thyroid dysfunction and heart failure events. METHODS AND RESULTS: We performed a pooled analysis of individual participant data using all available prospective cohorts with thyroid function tests and subsequent follow-up of heart failure events. Individual data on 25 390 participants with 216 248 person-years of follow-up were supplied from 6 prospective cohorts in the United States and Europe. Euthyroidism was defined as TSH of 0.45 to 4.49 mIU/L, subclinical hypothyroidism as TSH of 4.5 to 19.9 mIU/L, and subclinical hyperthyroidism as TSH <0.45 mIU/L, the last two with normal free thyroxine levels. Among 25 390 participants, 2068 (8.1%) had subclinical hypothyroidism and 648 (2.6%) had subclinical hyperthyroidism. In age- and sex-adjusted analyses, risks of heart failure events were increased with both higher and lower TSH levels (P for quadratic pattern <0.01); the hazard ratio was 1.01 (95% confidence interval, 0.81-1.26) for TSH of 4.5 to 6.9 mIU/L, 1.65 (95% confidence interval, 0.84-3.23) for TSH of 7.0 to 9.9 mIU/L, 1.86 (95% confidence interval, 1.27-2.72) for TSH of 10.0 to 19.9 mIU/L (P for trend <0.01) and 1.31 (95% confidence interval, 0.88-1.95) for TSH of 0.10 to 0.44 mIU/L and 1.94 (95% confidence interval, 1.01-3.72) for TSH <0.10 mIU/L (P for trend=0.047). Risks remained similar after adjustment for cardiovascular risk factors. CONCLUSION: Risks of heart failure events were increased with both higher and lower TSH levels, particularly for TSH ≥10 and <0.10 mIU/L. 相似文献
107.
Chabbi-Achengli Y Coudert AE Callebert J Geoffroy V Côté F Collet C de Vernejoul MC 《Proceedings of the National Academy of Sciences of the United States of America》2012,109(7):2567-2572
Peripheral serotonin, synthesized by tryptophan hydroxylase-1 (TPH(1)), has been shown to play a key role in several physiological functions. Recently, controversy has emerged about whether peripheral serotonin has any effect on bone density and remodeling.We therefore decided to investigate in detail bone remodeling in growing and mature TPH(1) knockout mice (TPH(1)(-/-)). Bone resorption in TPH(1)(-/-) mice, as assessed by biochemical markers and bone histomorphometry, was markedly decreased at both ages. Using bone marrow transplantation, we present evidence that the decrease in bone resorption in TPH(1)(-/-) mice is cell-autonomous. Cultures from TPH(1)(-/-) in the presence of macrophage colony-stimulating factor and receptor activator for NF-KB ligand (RANKL) displayed fewer osteoclasts, and the decreased differentiation could be rescued by adding serotonin. Our data also provide evidence that in the presence of RANKL, osteoclast precursors express TPH(1) and synthesize serotonin. Furthermore, pharmacological inhibition of serotonin receptor 1B with SB224289, and of receptor 2A with ketanserin, also reduced the number of osteoclasts. Our findings reveal that serotonin has an important local action in bone, as it can amplify the effect of RANKL on osteoclastogenesis. 相似文献
108.
G. Cayla J. Silvain P. Ecollan G. Montalescot J.-P. Collet 《Annales de cardiologie et d'angeiologie》2012
Improvement of myocardial reperfusion with a greater use of primary percutaneous coronary intervention, adjunctive pharmacological and mechanical therapies have contributed to a spectacular decrease in mortality of patients presenting with ST-elevation myocardial infarction. 相似文献
109.
Collet TH Gussekloo J Bauer DC den Elzen WP Cappola AR Balmer P Iervasi G Åsvold BO Sgarbi JA Völzke H Gencer B Maciel RM Molinaro S Bremner A Luben RN Maisonneuve P Cornuz J Newman AB Khaw KT Westendorp RG Franklyn JA Vittinghoff E Walsh JP Rodondi N;Thyroid Studies Collaboration 《Archives of internal medicine》2012,172(10):799-809
110.
Mebazaa A Vanpoucke G Thomas G Verleysen K Cohen-Solal A Vanderheyden M Bartunek J Mueller C Launay JM Van Landuyt N D'hondt F Verschuere E Vanhaute C Tuytten R Vanneste L De Cremer K Wuyts J Davies H Moerman P Logeart D Collet C Lortat-Jacob B Tavares M Laroy W Januzzi JL Samuel JL Kas K 《European heart journal》2012,33(18):2317-2324
Aims Biochemical marker testing has improved the evaluation and management of patients with cardiovascular diseases over the past decade. Natriuretic peptides (NPs), used in clinical practice to assess cardiac dysfunction, exhibit many limitations, however. We used an unbiased proteomics approach for the discovery of novel diagnostic plasma biomarkers of heart failure (HF). Methods and results A proteomics pipeline adapted for very low-abundant plasma proteins was applied to clinical samples from patients admitted with acute decompensated HF (ADHF). Quiescin Q6 (QSOX1), a protein involved in the formation of disulfide bridges, emerged as the best performing marker for ADHF (with an area under the receiver operator characteristic curve of 0.86, 95% confidence interval: 0.79-0.92), and novel isoforms of NPs were also identified. Diagnostic performance of QSOX1 for ADHF was confirmed in 267 prospectively collected subjects of whom 76 had ADHF. Combining QSOX1 to B-type NP (BNP) significantly improved diagnostic accuracy for ADHF by particularly improving specificity. Using thoracic aortic constriction in rats, QSOX1 was specifically induced within both left atria and ventricles at the time of HF onset. Conclusion The novel biomarker QSOX1 accurately identifies ADHF, particularly when combined with BNP. Through both clinical and experimental studies we provide lines of evidence for a link between ADHF and cardiovascular production of QSOX1. 相似文献